Crossmark

Potential of insulin deprescription adding a GLP-1 receptor agonist as a therapeutic strategy to improve the metabolic profiles of patients with type 2 diabetes mellitus

Crossref DOI link: https://doi.org/10.1016/j.endien.2024.11.007

Published Print: 2024-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Perez de Arenaza Pozo, Victor

Cárdenas Salas, Jersy

Vázquez Martínez, Clotilde
License Information

Text and Data Mining valid from 2024-11-01

Text and Data Mining valid from 2024-11-01
More Information

This article is maintained by: Elsevier

Article Title: Potential of insulin deprescription adding a GLP-1 receptor agonist as a therapeutic strategy to improve the metabolic profiles of patients with type 2 diabetes mellitus

Journal Title: Endocrinología, Diabetes y Nutrición (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endien.2024.11.007

Content Type: simple-article

Copyright: © 2024 SEEN and SED. Published by Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Document is current

Any future updates will be listed below